PT  - JOURNAL ARTICLE
AU  - Leighl, Natasha B
AU  - Redman, Mary W
AU  - Rizvi, Naiyer
AU  - Hirsch, Fred R
AU  - Mack, Philip C
AU  - Schwartz, Lawrence H
AU  - Wade, James L
AU  - Irvin, William J
AU  - Reddy, Sreekanth C
AU  - Crawford, Jeffrey
AU  - Bradley, Jeffrey D
AU  - Stinchcombe, Thomas E
AU  - Ramalingam, Suresh S
AU  - Miao, Jieling
AU  - Minichiello, Katherine
AU  - Herbst, Roy S
AU  - Papadimitrakopoulou, Vassiliki A
AU  - Kelly, Karen
AU  - Gandara, David R
TI  - Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)
AID  - 10.1136/jitc-2021-002973
DP  - 2021 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e002973
VI  - 9
IP  - 8
4099  - http://jitc.bmj.com/content/9/8/e002973.short
4100  - http://jitc.bmj.com/content/9/8/e002973.full
SO  - J Immunother Cancer2021 Aug 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.